Aignostics AI precision-oncology research collaboration

Bayer and Aignostics announced a multi-year collaboration to identify novel cancer targets with AI models on multimodal patient data, and to develop AI and machine-learning pathology algorithms that connect pathology and clinical data for trial patient identification, stratification and selection.